Delivery Order SPE2DB22D2214-SPE2DB25FS5YD
- Not listed
- The Defense Logistics Agency awarded a $14,002.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military...
- The Defense Logistics Agency (DLA) awarded a $20,188.16 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $67,384.37 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is firm fixed price with no set-aside designation, was competitively awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a $91,958.57 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $6,709.61 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, designated as a firm fixed price delivery order with no set-aside provisions, was competitively awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance. This delivery order represents a single...
- The Defense Logistics Agency awarded a $32,259.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a competitive award to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a $12,541.06 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of July 31, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a $35,070.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of July 23, 2025. This non-set-aside contract was competitively awarded on July 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $14,972.50 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 12, 2025. This competitive award, issued on August 11, 2025, utilizes firm fixed pricing and carries no set-aside designation. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5YDDelivery Order
The Defense Logistics Agency awarded a $122,324.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical products, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical vendor supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for ENBREL, a biologic treatment for rheumatoid arthritis and other autoimmune conditions, reflects the company's ongoing role in supplying specialized pharmaceutical commodities to support Defense Health Agency operations and broader federal healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $122.3k | 7/28/25 |